LabCompass

Michael Ozga

Medicine · The Ohio State University

Mid career · publishing since 2012

Publications

31

Citations

258

Est. group size

~11

Recurring co-author estimate

Active years

13

Publishing since 2012

Research summary
AI-generated

Michael Ozga's research focuses on blood cancers and bone marrow transplantation, particularly stem cell transplants used to treat conditions like myelofibrosis (a disorder where bone marrow is replaced by scar tissue) and T-cell lymphoma (a cancer of white blood cells). Much of the work involves large, multi-institutional studies comparing transplant approaches, including using partially matched ('haploidentical') donors combined with a chemotherapy drug (cyclophosphamide) given after transplant to reduce complications. This research is intended to inform treatment strategies for patients with rare and difficult-to-treat blood cancers.

Blood and bone marrow cancersStem cell and bone marrow transplantationMyelofibrosis and myeloproliferative disordersT-cell lymphoma treatmentMulticenter clinical outcomes research

Publication output rose sharply around 2020 and has since declined to a lower, fluctuating level through 2023-2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.0/year recently
17182019: 2 publications192020: 10 publications10202021: 4 publications212022: 4 publications222023: 5 publications232024: 1 publication242526
Publishes in
  • Blood×9
  • Clinical Lymphoma Myeloma & Leukemia×3
  • Leukemia×2
  • American Journal of Hematology×2
  • Biology of Blood and Marrow Transplantation×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile